248 related articles for article (PubMed ID: 31636172)
1. Interaction Between Type 2 Diabetes Prevention Strategies and Genetic Determinants of Coronary Artery Disease on Cardiometabolic Risk Factors.
Merino J; Jablonski KA; Mercader JM; Kahn SE; Chen L; Harden M; Delahanty LM; Araneta MRG; Walford GA; Jacobs SBR; Ibebuogu UN; Franks PW; Knowler WC; Florez JC;
Diabetes; 2020 Jan; 69(1):112-120. PubMed ID: 31636172
[TBL] [Abstract][Full Text] [Related]
2. Change in adiponectin explains most of the change in HDL particles induced by lifestyle intervention but not metformin treatment in the Diabetes Prevention Program.
Goldberg RB; Temprosa M; Mele L; Orchard T; Mather K; Bray G; Horton E; Kitabchi A; Krakoff J; Marcovina S; Perreault L; White N;
Metabolism; 2016 May; 65(5):764-775. PubMed ID: 27085783
[TBL] [Abstract][Full Text] [Related]
3. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
Flórez H
Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
[TBL] [Abstract][Full Text] [Related]
4. Associations of Combined Genetic and Lifestyle Risks With Incident Cardiovascular Disease and Diabetes in the UK Biobank Study.
Said MA; Verweij N; van der Harst P
JAMA Cardiol; 2018 Aug; 3(8):693-702. PubMed ID: 29955826
[TBL] [Abstract][Full Text] [Related]
5. Use of a Metabolic Syndrome Severity
DeBoer MD; Filipp SL; Gurka MJ
Diabetes Care; 2018 Nov; 41(11):2421-2430. PubMed ID: 30275282
[TBL] [Abstract][Full Text] [Related]
6. Genetics of type 2 diabetes and coronary artery disease and their associations with twelve cardiometabolic traits in the United Arab Emirates population.
Osman W; Hassoun A; Jelinek HF; Almahmeed W; Afandi B; Tay GK; Alsafar H
Gene; 2020 Aug; 750():144722. PubMed ID: 32360841
[TBL] [Abstract][Full Text] [Related]
7. Targeting the consequences of the metabolic syndrome in the Diabetes Prevention Program.
Goldberg RB; Mather K
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2077-90. PubMed ID: 22895669
[TBL] [Abstract][Full Text] [Related]
8. Limitations of Contemporary Guidelines for Managing Patients at High Genetic Risk of Coronary Artery Disease.
Aragam KG; Dobbyn A; Judy R; Chaffin M; Chaudhary K; Hindy G; Cagan A; Finneran P; Weng LC; Loos RJF; Nadkarni G; Cho JH; Kember RL; Baras A; Reid J; Overton J; Philippakis A; Ellinor PT; Weiss ST; Rader DJ; Lubitz SA; Smoller JW; Karlson EW; Khera AV; Kathiresan S; Do R; Damrauer SM; Natarajan P
J Am Coll Cardiol; 2020 Jun; 75(22):2769-2780. PubMed ID: 32498804
[TBL] [Abstract][Full Text] [Related]
9. Causal Effects of Intensive Lifestyle and Metformin Interventions on Cardiovascular Disease Risk Factors in Pre-Diabetic People: An Application of G-Estimation.
Salimi Y; Fotouhi A; Mohammad K; Mansournia N; Mansournia MA
Arch Iran Med; 2017 Jan; 20(1):55-59. PubMed ID: 28112533
[TBL] [Abstract][Full Text] [Related]
10. Genetic modulation of lipid profiles following lifestyle modification or metformin treatment: the Diabetes Prevention Program.
Pollin TI; Isakova T; Jablonski KA; de Bakker PI; Taylor A; McAteer J; Pan Q; Horton ES; Delahanty LM; Altshuler D; Shuldiner AR; Goldberg RB; Florez JC; Franks PW;
PLoS Genet; 2012; 8(8):e1002895. PubMed ID: 22951888
[TBL] [Abstract][Full Text] [Related]
11. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.
Orchard TJ; Temprosa M; Goldberg R; Haffner S; Ratner R; Marcovina S; Fowler S;
Ann Intern Med; 2005 Apr; 142(8):611-9. PubMed ID: 15838067
[TBL] [Abstract][Full Text] [Related]
12. Interactions Between Enhanced Polygenic Risk Scores and Lifestyle for Cardiovascular Disease, Diabetes, and Lipid Levels.
Ye Y; Chen X; Han J; Jiang W; Natarajan P; Zhao H
Circ Genom Precis Med; 2021 Feb; 14(1):e003128. PubMed ID: 33433237
[TBL] [Abstract][Full Text] [Related]
13. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
; Knowler WC; Fowler SE; Hamman RF; Christophi CA; Hoffman HJ; Brenneman AT; Brown-Friday JO; Goldberg R; Venditti E; Nathan DM
Lancet; 2009 Nov; 374(9702):1677-86. PubMed ID: 19878986
[TBL] [Abstract][Full Text] [Related]
14. Effects of exercise training alone vs a combined exercise and nutritional lifestyle intervention on glucose homeostasis in prediabetic individuals: a randomised controlled trial.
Slentz CA; Bateman LA; Willis LH; Granville EO; Piner LW; Samsa GP; Setji TL; Muehlbauer MJ; Huffman KM; Bales CW; Kraus WE
Diabetologia; 2016 Oct; 59(10):2088-98. PubMed ID: 27421729
[TBL] [Abstract][Full Text] [Related]
15. Targeting of the diabetes prevention program leads to substantial benefits when capacity is constrained.
Olchanski N; van Klaveren D; Cohen JT; Wong JB; Ruthazer R; Kent DM
Acta Diabetol; 2021 Jun; 58(6):707-722. PubMed ID: 33517494
[TBL] [Abstract][Full Text] [Related]
16. Effect of a Lifestyle Intervention Program With Energy-Restricted Mediterranean Diet and Exercise on Weight Loss and Cardiovascular Risk Factors: One-Year Results of the PREDIMED-Plus Trial.
Salas-Salvadó J; Díaz-López A; Ruiz-Canela M; Basora J; Fitó M; Corella D; Serra-Majem L; Wärnberg J; Romaguera D; Estruch R; Vidal J; Martínez JA; Arós F; Vázquez C; Ros E; Vioque J; López-Miranda J; Bueno-Cavanillas A; Tur JA; Tinahones FJ; Martín V; Lapetra J; Pintó X; Daimiel L; Delgado-Rodríguez M; Matía P; Gómez-Gracia E; Díez-Espino J; Babio N; Castañer O; Sorlí JV; Fiol M; Zulet MÁ; Bulló M; Goday A; Martínez-González MÁ;
Diabetes Care; 2019 May; 42(5):777-788. PubMed ID: 30389673
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Analysis of Established Dyslipidemia-Associated Loci in the Diabetes Prevention Program.
Varga TV; Winters AH; Jablonski KA; Horton ES; Khare-Ranade P; Knowler WC; Marcovina SM; Renström F; Watson KE; Goldberg R; Florez JC; Pollin TI; Franks PW
Circ Cardiovasc Genet; 2016 Dec; 9(6):495-503. PubMed ID: 27784733
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of Diabetes Prevention Interventions Targeting High-risk Individuals and Whole Populations: A Systematic Review.
Zhou X; Siegel KR; Ng BP; Jawanda S; Proia KK; Zhang X; Albright AL; Zhang P
Diabetes Care; 2020 Jul; 43(7):1593-1616. PubMed ID: 33534726
[TBL] [Abstract][Full Text] [Related]
19. The Impact of a Yearlong Diabetes Prevention Program-Based Lifestyle Intervention on Cardiovascular Health Metrics.
Devaraj SM; Rockette-Wagner B; Miller RG; Arena VC; Napoleone JM; Conroy MB; Kriska AM
J Prim Care Community Health; 2021; 12():21501327211029816. PubMed ID: 34236004
[TBL] [Abstract][Full Text] [Related]
20. Intensive lifestyle changes or metformin in patients with impaired glucose tolerance: modeling the long-term health economic implications of the diabetes prevention program in Australia, France, Germany, Switzerland, and the United Kingdom.
Palmer AJ; Roze S; Valentine WJ; Spinas GA; Shaw JE; Zimmet PZ
Clin Ther; 2004 Feb; 26(2):304-21. PubMed ID: 15038953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]